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Background: According to WHO, CDC, IDSA and ATS guidelines,
atients with pulmonary tuberculosis (Tb) can be considered as
on infectious when: 1) they are receiving multiple drugs for 2 to
weeks; 2) there is an improvement in clinical condition; 3) the
ikelihood of MDR-Tb is very small. Objective: To determine the
ime for sputum reversion since the start of anti-Tb treatment in
risoners from four jails in Medellin and Bucaramanga, Colombia
etween May 2010 to April 2011.
Methods: Prospective cohort study. All prisoners diagnosed
ith Tb by sputum smear or culture were followed for two years:
onthly for the ﬁrst six months after the start of treatment,
imonthly the next sixmonths, and quarterly the second year. Dur-
ng follow-up, we took two spontaneous and one induced sputum
amples for auramine-rodhamine stain, and cultures in thin layer
gar, Löwestein-Jensen andMGIT for the both ﬁrst samples.We did
ime to event analysis.
Results: We could follow 45 of 47 positive patients (one was
ransferred to another jail and one Tb-related death). The median
or sputum smear reversion was 33 days (IQR: 31-60), and for cul-
ure was 55 days (IQR: 32-68). 90% of the patients had sputum
mear and culture negative at 102 days. The time for sputum to
ecome negative by culture had a positive correlation with the
putum grade at the moment of diagnosis: negative smear with
ositive culture= median 31.5 days, smear with 1+=58.5 days,
mear 2+=62 days, and smear 3+=65 days (p value =0.007).
Conclusion: After starting treatment the reversion of cultures
ook twoormoremonths in≥50%cases. That is forcingus to rethink
he recommendations about the isolation of patients with pul-
onary Tb in prisons, and suggests the need to use mycobacterial
ultures on sputum to follow-up those patients.
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Evaluating the cost-effectiveness of TB diagnostic strategies in
HIV-positive patients in Lusaka, Zambia
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Background: Zambia is a high burden country for both human
immunodeﬁciency virus (HIV) and tuberculosis (TB) infection and
HIV clinic enrollees are a high-risk group for active TB. The
advent of low-cost rapid-diagnostic technologies for TB, such as
the Gene Xpert MTB/RIF assay and microscopic-observation drug-
susceptibility (MODS) culture, suggest an affordable and promising
diagnostic method to quickly identify and treat cases, but the cost-
effectiveness of these tests are not well-established in high burden
areas with a high prevalence of HIV.
Methods: The objective of this study was to determine the cost-
effectiveness of different TB diagnostic strategies in a cohort of
HIV-infected patients in Lusaka. A cost-effectiveness analysis (CEA)
was carried out using decision analysis modeling. Using the cohort
proportions of HIV clinic enrollees at the Centre for Infectious
Disease Research in Zambia (CIDRZ), the analysis compared the fol-
lowing strategies: standard of care TB diagnosis (a combination of
symptomscreening, sputumsmearmicroscopy, andchest x-ray ina
diagnostic algorithm), enhancedTB screening (symptomscreening,
sputum smear microscopy, chest x-ray and TB culture), Gene Xpert
MTB/RIF Assay, MODS, and empiric treatment. Outcomes analyzed
were number of cases of active pulmonary TB diagnosed and incre-
mental cost-effectiveness ratios (ICERS).
Results: Preliminary results from the base case analysis found
that the standard of care was US$75.74 per case of TB detected,
US$327.80 per case detected using enhanced screening, US$108.90
per case detected using Xpert, and US$41.74 per case detected
using MODS. The ICERS ranged from US$34.00 per case averted
usingMODSorXpert toUS$252.00per case avertedusing enhanced
screening, where the standard of care was the comparison group.
Conclusion: The decision analysis model suggests that using
rapid diagnostics, particularlyMODS, is very cost-effective for diag-
nosing TB in HIV clinic enrollees in Lusaka, Zambia.
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